A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare

NACompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 4, 2016

Study Completion Date

January 2, 2021

Conditions
Healthy Adults (Full Study and Extension Phase)Hypertrophic Cardiomyopathy or Dilated Cardiomyopathy
Interventions
OTHER

Family History + Whole Genome Sequencing

"Doctors and their patients receive a Genome Report and a Family History report.~There are two sections of the Genome Report:~1. The General Genome Report, which include highly penetrant disease mutations, carrier status for recessive disease, and pharmacogenetic associations.~2. The Cardiac Risk Supplement, which contain genetic information found in the genome regarding cardiac diseases or a risk of cardiovascular diseases that can help with the care of the patient.~Extension Phase: Experimental: Family History + Whole Genome Sequencing~\*In the main study participants are randomized to either the Experimental or Other Arm, in the Extension phase of the study all participants are in the Experimental Arm."

OTHER

Family History Only

Doctors and their patients receive a Family History report.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Human Genome Research Institute (NHGRI)

NIH

collaborator

Baylor College of Medicine

OTHER

collaborator

Duke University

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT01736566 - A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare | Biotech Hunter | Biotech Hunter